{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:21:22Z","timestamp":1791206482137,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantation-proceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.transproceed.2014.09.029","type":"journal-article","created":{"date-parts":[[2014,11,7]],"date-time":"2014-11-07T12:31:09Z","timestamp":1415363469000},"page":"2618-2621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Non-HLA Antibodies: Angiotensin II Type 1 Receptor (Anti-AT1R) and Endothelin-1 Type A Receptor (Anti-ETAR) Are Associated With Renal Allograft Injury and Graft Loss"],"prefix":"10.1016","volume":"46","author":[{"given":"M.","family":"Banasik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boraty\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ko\u015bcielska-Kasprzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zmonarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Mazanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Krajewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bartoszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"\u017babi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Myszka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kami\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ha\u0142o\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Dawiskiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Szyber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2014.09.029_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MOT.0b013e3283636e55","article-title":"Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance","volume":"18","author":"Dragun","year":"2013","journal-title":"Current Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2014.09.029_bib2","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.09.029_bib3","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.09.029_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e3182692ad2","article-title":"Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation","volume":"94","author":"Hiemann","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.09.029_bib5","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.transproceed.2012.12.026","article-title":"The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome","volume":"45","author":"Banasik","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.09.029_bib6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A\u00a0novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.transproceed.2014.09.029_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000170845","article-title":"Non-HLA antibodies post-transplantation: clinical relevance and treatment in solid organ transplantation","volume":"162","author":"Dragun","year":"2009","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.transproceed.2014.09.029_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/TP.0b013e3182483713","article-title":"A\u00a0personal perspective: 100-year history of the humoral theory of transplantation","volume":"93","author":"Terasaki","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.09.029_bib9","first-page":"7","article-title":"Chronic allograft nephropathy\u2014immunologic and nonimmunologic factors","volume":"11","author":"Banasik","year":"2006","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2014.09.029_bib10","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.transproceed.2007.08.064","article-title":"C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients","volume":"39","author":"Banasik","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.09.029_bib11","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1016\/j.transproceed.2007.08.054","article-title":"Variability in donor-specific alloantibody production after transplantation","volume":"39","author":"Banasik","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.09.029_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/TP.0b013e31827a19cc","article-title":"Consensus guidelines on the testing and clinical management issues associated with HLA and Non-HLA antibodies in transplantation","volume":"95","author":"Tait","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.09.029_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trim.2013.10.007","article-title":"The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes","volume":"30","author":"Banasik","year":"2013","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2014.09.029_bib14","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.transproceed.2012.11.025","article-title":"Long-term follow-up of non-HLA and anti-HLA antibodies: incidence and importance in renal transplantation","volume":"45","author":"Banasik","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.09.029_bib15","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/j.1600-6143.2005.01016.x","article-title":"Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure","volume":"5","author":"Mizutani","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.09.029_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1146\/annurev.pharmtox.47.120505.105134","article-title":"Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease","volume":"47","author":"Schneider","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.transproceed.2014.09.029_bib17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/pr900930d","article-title":"Identification of Non-HLA antigens targeted by alloreactive antibodies in patients undergoing chronic hemodialysis","volume":"9","author":"Bilalic","year":"2010","journal-title":"J\u00a0Proteome Res"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451400815X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451400815X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T19:50:40Z","timestamp":1538077840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113451400815X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S004113451400815X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.029","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-HLA Antibodies: Angiotensin II Type 1 Receptor (Anti-AT1R) and Endothelin-1 Type A Receptor (Anti-ETAR) Are Associated With Renal Allograft Injury and Graft Loss","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}